Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: GSK 10.595, BioNTech 0.114.
GSK vs BioNTech: Revenue Comparison
GSK (GSK) and BioNTech (BNTX) are peers in Vaccines. GSK reported revenue of $10.6B as of Q2 2026, compared with $114M for BioNTech. GSK leads on revenue.
GSK's gross margin is 73.0% versus 8.1% for BioNTech. GSK's net margin is 5.2% versus -777.3% for BioNTech.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, GSK, BioNTech.| Metric | GSK | BioNTech |
|---|---|---|
| Market Cap | - | - |
| Revenue | $10.60B | $114.00M |
| Cost of Revenue | $2.85B | $105.00M |
| Gross Profit | $7.74B | $9.00M |
| Operating Income | $606.00M | $-1.02B |
| Net Income | $548.00M | $-886.00M |
| R&D Expense | $4.37B | $595.00M |
| Earnings Per Share | $0.28 | -$3.5 |
| Gross Margin | 73.0% | 8.1% |
| Operating Margin | 5.7% | -897.8% |
| Net Profit Margin | 5.2% | -777.3% |
| Free Cash Flow | $2.78B | $-48.00M |
| Cumulative Free Cash Flow | $157.21B | $19.56B |
| Operating Cash Flow | $3.19B | $12.00M |
| Cash & Equivalents | $3.89B | $10.52B |